Technology
Marvell Technology, Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Published
1 year agoon
By
Q4 Net Revenue: $1.817 billion, grew by 27% year-on-yearQ4 Gross Margin: 50.5% GAAP gross margin; 60.1% non-GAAP gross marginQ4 Diluted income per share: $0.23 GAAP diluted income per share; $0.60 non-GAAP diluted income per share
SANTA CLARA, Calif., March 5, 2025 /PRNewswire/ — Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today reported financial results for the fourth fiscal quarter and fiscal year ended February 1, 2025.
Net revenue for the fourth quarter of fiscal 2025 was $1.817 billion, $17.0 million above the mid-point of the Company’s guidance provided on December 3, 2024. GAAP net income for the fourth quarter of fiscal 2025 was $200.2 million, or $0.23 per diluted share. Non-GAAP net income for the fourth quarter of fiscal 2025 was $531.4 million, or $0.60 per diluted share. Cash flow from operations for the fourth quarter was $514.0 million.
Net revenue for fiscal 2025 was $5.767 billion. GAAP net loss for fiscal 2025 was $(885.0) million, or $(1.02) per diluted share. Non-GAAP net income for fiscal 2025 was $1.377 billion, or $1.57 per diluted share.
“We closed fiscal year 2025 on a high note, delivering record fourth-quarter revenue of $1.817 billion – an increase of 20% sequentially and 27% year-over-year. This performance was driven by strong growth in our data center end market, where revenue increased 78% year-over-year in the fourth quarter, along with a continued recovery in our multi-market businesses. For the full fiscal year, we delivered a record $1.68 billion in operating cash flow and returned $933 million to stockholders through stock repurchases and dividends,” said Matt Murphy, Marvell’s Chairman and CEO. “Our custom AI silicon programs have now entered volume production, and we continue to see strong growth from our interconnect products. Marvell has secured multiple new design wins, including several custom silicon programs that will fuel future growth. We are well positioned for a strong start to fiscal 2026. We expect first-quarter revenue growth of over 60 percent year-over-year at the mid-point of guidance, and we anticipate strong revenue growth for the full fiscal year.”
First Quarter of Fiscal 2026 Financial Outlook
Net revenue is expected to be $1.875 billion +/- 5%.GAAP gross margin is expected to be approximately 50.5%.Non-GAAP gross margin is expected to be approximately 60%.GAAP operating expenses are expected to be approximately $712 million.Non-GAAP operating expenses are expected to be approximately $490 million.Basic weighted-average shares outstanding are expected to be 867 million.Diluted weighted-average shares outstanding are expected to be 880 million.GAAP diluted net income per share is expected to be $0.19 +/- $0.05 per share.Non-GAAP diluted net income per share is expected to be $0.61 +/- $0.05 per share.
GAAP diluted EPS is calculated using basic weighted-average shares outstanding when there is a GAAP net loss, and calculated using diluted weighted-average shares outstanding when there is a GAAP net income. Non-GAAP diluted EPS is calculated using diluted weighted-average shares outstanding.
Conference Call
Marvell will conduct a conference call on Wednesday, March 5, 2025 at 1:45 p.m. Pacific Time to discuss results for the fourth quarter and fiscal year 2025. Interested parties may join the conference call without operator assistance by registering and entering their phone number at https://emportal.ink/4h8OI7Q to receive an instant automated call back. To join the call with operator assistance, please dial 1-800-836-8184 or 1-646-357-8785. The call will be webcast and can be accessed at the Marvell Investor Relations website at http://investor.marvell.com/. A replay of the call can be accessed by dialing 1-888-660-6345 or 1-646-517-4150, passcode 19355# until Wednesday, March 12, 2025.
Discussion of Non-GAAP Financial Measures
Non-GAAP financial measures exclude the effect of stock-based compensation expense, amortization of acquired intangible assets, acquisition and divestiture-related costs, restructuring and other related charges (including, but not limited to, asset impairment charges, recognition of future contractual obligations, employee severance costs, and facility exit related charges), resolution of legal matters, and certain expenses and benefits that are driven primarily by discrete events that management does not consider to be directly related to Marvell’s core business. Although Marvell excludes the amortization of all acquired intangible assets from these non-GAAP financial measures, management believes that it is important for investors to understand that such intangible assets were recorded as part of purchase price accounting arising from acquisitions, and that such amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Investors should note that the use of intangible assets contributed to Marvell’s revenues earned during the periods presented and are expected to contribute to Marvell’s future period revenues as well.
Marvell uses a non-GAAP tax rate to compute the non-GAAP tax provision. This non-GAAP tax rate is based on Marvell’s estimated annual GAAP income tax forecast, adjusted to account for items excluded from Marvell’s non-GAAP income, as well as the effects of significant non-recurring and period specific tax items which vary in size and frequency, and excludes tax deductions and benefits from acquired tax loss and credit carryforwards and changes in valuation allowance on acquired deferred tax assets. Marvell’s non-GAAP tax rate is determined on an annual basis and may be adjusted during the year to take into account events that may materially affect the non-GAAP tax rate such as tax law changes; acquisitions; significant changes in Marvell’s geographic mix of revenue and expenses; or changes to Marvell’s corporate structure. For the fourth quarter of fiscal 2025, a non-GAAP tax rate of 7.0% has been applied to the non-GAAP financial results.
Marvell believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to Marvell’s financial condition and results of operations. While Marvell uses non-GAAP financial measures as a tool to enhance its understanding of certain aspects of its financial performance, Marvell does not consider these measures to be a substitute for, or superior to, financial measures calculated in accordance with GAAP. Consistent with this approach, Marvell believes that disclosing non-GAAP financial measures to the readers of its financial statements provides such readers with useful supplemental data that, while not a substitute for GAAP financial measures, allows for greater transparency in the review of its financial and operational performance.
Externally, management believes that investors may find Marvell’s non-GAAP financial measures useful in their assessment of Marvell’s operating performance and the valuation of Marvell. Internally, Marvell’s non-GAAP financial measures are used in the following areas:
Management’s evaluation of Marvell’s operating performance;Management’s establishment of internal operating budgets;Management’s performance comparisons with internal forecasts and targeted business models; andManagement’s determination of the achievement and measurement of certain types of compensation including Marvell’s annual incentive plan and certain performance-based equity awards (adjustments may vary from award to award).
Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of Marvell’s business as determined in accordance with GAAP. As a result, you should not consider these measures in isolation or as a substitute for analysis of Marvell’s results as reported under GAAP. The exclusion of the above items from our GAAP financial metrics does not necessarily mean that these costs are unusual or infrequent.
Forward-Looking Statements under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the “safe harbor” created by those sections. These statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results to differ materially from those implied by the forward-looking statements. Words such as “anticipates,” “expects,” “intends,” “plans,” “projects,” “believes,” “seeks,” “estimates,” “forecasts,” “targets,” “may,” “can,” “will,” “would” and similar expressions identify such forward-looking statements. Forward-looking statements contained in this press release include, but are not limited to, the statements describing our financial outlook and future period revenues. These statements are not guarantees of results and should not be considered as an indication of future activity or future performance. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Actual events or results may differ materially from those described in this press release due to a number of risks and uncertainties, including, but not limited to: risks related to our ability to estimate customer demand and future sales accurately; our ability to define, design, develop and market products for the Artificial Intelligence (AI), Cloud, and 5G markets; risks related to our dependence on a few customers for a significant portion of our revenue, particularly as our major customers comprise an increasing percentage of our revenue, as well as risks related to a significant portion of our sales being concentrated in the data center end market; risks that our customers develop their own solutions, vertically integrate which may reduce the need for our products, or acquire fully developed solutions from third parties; our ability to secure design wins from our customers and prospective customers; the impact of international conflict (such as the current armed conflicts in the Ukraine and in Israel and the Gaza Strip) and economic volatility in either domestic or foreign markets including risks related to trade conflicts or tensions, regulations, and tariffs, including but not limited to, trade restrictions imposed on our Chinese customers; risks related to changes in general macroeconomic conditions, or expectations of such conditions, such as high or rising interest rates, macroeconomic slowdowns, recessions, inflation, and stagflation; risks related to higher inventory levels; risks related to cancellations, rescheduling or deferrals of significant customer orders or shipments, as well as the ability of our customers to manage inventory; our ability to realize the expected benefits from restructuring activities; the risk of downturns in the semiconductor industry or our customer end markets; our ability to retain and hire key personnel; risks related to our return to working full time in the office as of June 2025; cybersecurity risks; our ability to limit costs related to defective products; risks related to our debt obligations; risks related to the rapid growth of the Company; delays or increased costs related to completing the design, development, production and introduction of our new products due to a variety of issues, including supply chain cross-dependencies, dependencies on EDA and similar tools, dependencies on the use of third-party, business partner or customer intellectual property, collaboration and synchronization requirements with business partners and customers, requirements to establish new manufacturing, testing, assembly and packing processes, and other issues; our reliance on our manufacturing partners for the manufacture, assembly, testing and packaging of our products; risks related to the ASIC business model which requires us to use third-party IP including the risk that we may lose business or experience reputational harm if third parties, including customers, lose confidence in our ability to protect their IP rights; the risks associated with manufacturing and selling products and customers’ products outside of the United States; our ability to complete and realize the anticipated benefits of any acquisitions, divestitures and investments; decreases in gross margin and results of operations in the future due to a number of factors, including high or increasing interest rates and volatility in foreign exchange rates; severe financial hardship or bankruptcy of one or more of our major customers; the effects of transitioning to smaller geometry process technologies; the impact of any change in the income tax laws in jurisdictions where we operate and the loss of any beneficial tax treatment that we currently enjoy; the outcome of pending or future litigation and legal and regulatory proceedings; risk related to our Sustainability program; the impact and costs associated with changes in international financial and regulatory conditions; our ability and the ability of our customers to successfully compete in the markets in which we serve; our ability and our customers’ ability to develop new and enhanced products and the adoption of those products in the market; supply chain disruptions or component shortages that may impact the production of our products including our kitting process or may impact the price of components which in turn may impact our margins on any impacted products and any constrained availability from other electronic suppliers impacting our customers’ ability to ship their products, which in turn may adversely impact our sales to those customers; our ability to scale our operations in response to changes in demand for existing or new products and services; risks associated with acquisition and consolidation activity in the semiconductor industry, including any consolidation of our manufacturing partners; our ability to protect our intellectual property; risks related to the impact of the COVID-19 pandemic (or future pandemics) which have impacted, and for which lingering effects may continue to impact our business, employees and operations, the transportation and manufacturing of our products, and the operations of our customers, distributors, vendors, suppliers, and partners; our maintenance of an effective system of internal controls; financial institution instability; and other risks detailed in our SEC filings from time to time. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties that affect our business described in the “Risk Factors” section of our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other documents filed by us from time to time with the SEC. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
About Marvell
To deliver the data infrastructure technology that connects the world, we’re building solutions on the most powerful foundation: our partnerships with our customers. Trusted by the world’s leading technology companies for over 25 years, we move, store, process and secure the world’s data with semiconductor solutions designed for our customers’ current needs and future ambitions. Through a process of deep collaboration and transparency, we’re ultimately changing the way tomorrow’s enterprise, cloud, automotive, and carrier architectures transform—for the better.
Marvell® and the Marvell logo are registered trademarks of Marvell and/or its affiliates.
Marvell Technology, Inc.
Condensed Consolidated Statements of Operations (Unaudited)
(In millions, except per share amounts)
Three Months Ended
Year Ended
February 1,
2025
November 2,
2024
February 3,
2024
February 1,
2025
February 3,
2024
Net revenue
$ 1,817.4
$ 1,516.1
$ 1,426.5
$ 5,767.3
$ 5,507.7
Cost of goods sold
900.0
1,166.7
762.4
3,385.1
3,214.1
Gross profit
917.4
349.4
664.1
2,382.2
2,293.6
Operating expenses:
Research and development
499.0
488.6
459.6
1,950.4
1,896.2
Selling, general and administrative
195.7
205.3
212.0
798.2
834.0
Restructuring related charges
(12.5)
358.3
25.8
353.9
131.1
Total operating expenses
682.2
1,052.2
697.4
3,102.5
2,861.3
Operating income (loss)
235.2
(702.8)
(33.3)
(720.3)
(567.7)
Interest expense
(45.0)
(47.2)
(52.6)
(189.4)
(211.7)
Interest income and other, net
9.6
(0.5)
(1.4)
15.0
20.7
Interest and other loss, net
(35.4)
(47.7)
(54.0)
(174.4)
(191.0)
Income (loss) before income taxes
199.8
(750.5)
(87.3)
(894.7)
(758.7)
Provision (benefit) for income taxes
(0.4)
(74.2)
305.4
(9.7)
174.7
Net income (loss)
$ 200.2
$ (676.3)
$ (392.7)
$ (885.0)
$ (933.4)
Net income (loss) per share — basic
$ 0.23
$ (0.78)
$ (0.45)
$ (1.02)
$ (1.08)
Net income (loss) per share — diluted
$ 0.23
$ (0.78)
$ (0.45)
$ (1.02)
$ (1.08)
Weighted-average shares:
Basic
865.7
865.7
864.7
865.5
861.3
Diluted
879.9
865.7
864.7
865.5
861.3
Marvell Technology, Inc.
Condensed Consolidated Balance Sheets (Unaudited)
(In millions)
February 1,
2025
February 3,
2024
Assets
Current assets:
Cash and cash equivalents
$ 948.3
$ 950.8
Accounts receivable, net
1,028.4
1,121.6
Inventories
1,029.7
864.4
Prepaid expenses and other current assets
113.9
125.9
Total current assets
3,120.3
3,062.7
Property and equipment, net
790.5
756.0
Goodwill
11,586.9
11,586.9
Acquired intangible assets, net
2,710.6
4,004.1
Deferred tax assets
401.2
311.9
Other non-current assets
1,595.0
1,506.9
Total assets
$ 20,204.5
$ 21,228.5
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
$ 622.2
$ 411.3
Accrued liabilities
972.6
1,032.9
Accrued employee compensation
302.5
262.7
Short-term debt
129.5
107.3
Total current liabilities
2,026.8
1,814.2
Long-term debt
3,934.3
4,058.6
Other non-current liabilities
816.4
524.3
Total liabilities
6,777.5
6,397.1
Stockholders’ equity:
Common stock
1.7
1.7
Additional paid-in capital
14,534.1
14,845.3
Accumulated other comprehensive income
0.4
1.1
Accumulated deficit
(1,109.2)
(16.7)
Total stockholders’ equity
13,427.0
14,831.4
Total liabilities and stockholders’ equity
$ 20,204.5
$ 21,228.5
Marvell Technology, Inc.
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Three Months Ended
Year Ended
February 1,
2025
February 3,
2024
February 1,
2025
February 3,
2024
Cash flows from operating activities:
Net income (loss)
$ 200.2
$ (392.7)
$ (885.0)
$ (933.4)
Adjustments to reconcile net income (loss) to net cash provided by operating
activities:
Depreciation and amortization
78.8
73.8
304.3
299.8
Stock-based compensation
147.6
155.3
597.4
609.8
Amortization of acquired intangible assets
247.1
286.3
1,052.6
1,097.9
Restructuring related impairment charges
4.7
0.7
528.8
32.9
Deferred income taxes
(5.7)
434.5
(111.9)
150.8
Other expense, net
23.8
15.0
65.9
54.9
Changes in assets and liabilities, net of acquisitions:
Accounts receivable
(30.5)
93.0
93.2
70.6
Prepaid expenses and other assets
(172.8)
(107.5)
3.4
(93.1)
Inventories
(169.8)
78.8
(230.0)
201.9
Accounts payable
71.7
(61.6)
181.5
(149.1)
Accrued employee compensation
31.6
17.6
43.5
18.3
Accrued liabilities and other non-current liabilities
87.3
(46.6)
37.5
9.2
Net cash provided by operating activities
514.0
546.6
1,681.2
1,370.5
Cash flows from investing activities:
Purchases of technology licenses
(0.8)
(10.6)
(7.0)
(13.9)
Purchases of property and equipment
(69.9)
(71.0)
(284.6)
(336.3)
Acquisitions, net of cash acquired
—
—
(10.4)
—
Other, net
0.4
(0.1)
1.3
(0.3)
Net cash used in investing activities
(70.3)
(81.7)
(300.7)
(350.5)
Cash flows from financing activities:
Repurchases of common stock
(200.0)
(100.0)
(725.0)
(150.0)
Proceeds from employee stock plans
35.2
38.1
87.6
99.2
Tax withholding paid on behalf of employees for net share settlement
(84.6)
(55.0)
(274.9)
(223.7)
Dividend payments to stockholders
(51.9)
(51.9)
(207.5)
(206.8)
Payments on technology license obligations
(29.2)
(40.1)
(153.6)
(150.3)
Proceeds from borrowings
—
—
—
1,295.3
Principal payments of debt
(32.8)
(21.9)
(109.4)
(1,622.5)
Other, net
(0.2)
(8.9)
(0.2)
(21.4)
Net cash used in financing activities
(363.5)
(239.7)
(1,383.0)
(980.2)
Net increase (decrease) in cash and cash equivalents
80.2
225.2
(2.5)
39.8
Cash and cash equivalents at beginning of period
868.1
725.6
950.8
911.0
Cash and cash equivalents at end of period
$ 948.3
$ 950.8
$ 948.3
$ 950.8
Marvell Technology, Inc.
Reconciliations from GAAP to Non-GAAP (Unaudited)
(In millions, except per share amounts)
Three Months Ended
Year Ended
February 1,
2025
November 2,
2024
February 3,
2024
February 1,
2025
February 3,
2024
GAAP gross profit
$ 917.4
$ 349.4
$ 664.1
$ 2,382.2
$ 2,293.6
Special items:
Stock-based compensation
10.1
16.3
10.4
47.3
49.1
Amortization of acquired intangible assets
169.5
180.4
194.3
721.7
748.1
Restructuring related charges (a)
1.1
356.8
—
357.9
—
Other cost of goods sold (b)
(6.1)
14.2
42.3
11.5
280.1
Total special items
174.6
567.7
247.0
1,138.4
1,077.3
Non-GAAP gross profit
$ 1,092.0
$ 917.1
$ 911.1
$ 3,520.6
$ 3,370.9
GAAP gross margin
50.5 %
23.0 %
46.6 %
41.3 %
41.6 %
Stock-based compensation
0.6 %
1.1 %
0.7 %
0.8 %
0.9 %
Amortization of acquired intangible assets
9.3 %
11.9 %
13.6 %
12.5 %
13.6 %
Restructuring related charges (a)
0.1 %
23.5 %
— %
6.2 %
— %
Other cost of goods sold (b)
(0.4) %
1.0 %
3.0 %
0.2 %
5.1 %
Non-GAAP gross margin
60.1 %
60.5 %
63.9 %
61.0 %
61.2 %
Total GAAP operating expenses
$ 682.2
$ 1,052.2
$ 697.4
$ 3,102.5
$ 2,861.3
Special items:
Stock-based compensation
(137.5)
(142.1)
(144.9)
(550.1)
(560.7)
Amortization of acquired intangible assets
(77.6)
(84.5)
(92.0)
(330.9)
(349.8)
Restructuring related charges (a)
12.5
(358.3)
(25.8)
(353.9)
(131.1)
Other (c)
(0.2)
(0.4)
(6.2)
(11.7)
(47.5)
Total special items
(202.8)
(585.3)
(268.9)
(1,246.6)
(1,089.1)
Total non-GAAP operating expenses
$ 479.4
$ 466.9
$ 428.5
$ 1,855.9
$ 1,772.2
GAAP operating margin
12.9 %
(46.4) %
(2.3) %
(12.5) %
(10.3) %
Stock-based compensation
8.1 %
10.5 %
10.9 %
10.4 %
11.1 %
Amortization of acquired intangible assets
13.6 %
17.5 %
20.1 %
18.3 %
19.9 %
Restructuring related charges (a)
(0.6) %
47.2 %
1.8 %
12.3 %
2.4 %
Other cost of goods sold (b)
(0.3) %
0.9 %
3.0 %
0.2 %
5.1 %
Other (c)
— %
— %
0.3 %
0.2 %
0.8 %
Non-GAAP operating margin
33.7 %
29.7 %
33.8 %
28.9 %
29.0 %
GAAP interest and other loss, net
$ (35.4)
$ (47.7)
$ (54.0)
$ (174.4)
$ (191.0)
Special items:
Other (c)
(5.8)
(1.4)
(1.3)
(9.3)
(13.9)
Total special items
(5.8)
(1.4)
(1.3)
(9.3)
(13.9)
Total non-GAAP interest and other loss, net
$ (41.2)
$ (49.1)
$ (55.3)
$ (183.7)
$ (204.9)
GAAP net income (loss)
$ 200.2
$ (676.3)
$ (392.7)
$ (885.0)
$ (933.4)
Special items:
Stock-based compensation
147.6
158.4
155.3
597.4
609.8
Amortization of acquired intangible assets
247.1
264.9
286.3
1,052.6
1,097.9
Restructuring related charges (a)
(11.4)
715.1
25.8
711.8
131.1
Other cost of goods sold (b)
(6.1)
14.2
42.3
11.5
280.1
Other (c)
(5.6)
(1.0)
4.9
2.4
33.6
Pre-tax total special items
371.6
1,151.6
514.6
2,375.7
2,152.5
Other income tax effects and adjustments (d)
(40.4)
(102.3)
279.7
(113.4)
91.0
Non-GAAP net income
$ 531.4
$ 373.0
$ 401.6
$ 1,377.3
$ 1,310.1
GAAP weighted-average shares — basic
865.7
865.7
864.7
865.5
861.3
GAAP weighted-average shares — diluted
879.9
865.7
864.7
865.5
861.3
Non-GAAP weighted-average shares — diluted (e)
879.9
875.5
873.9
876.8
869.3
GAAP diluted net income (loss) per share
$ 0.23
$ (0.78)
$ (0.45)
$ (1.02)
$ (1.08)
Non-GAAP diluted net income per share
$ 0.60
$ 0.43
$ 0.46
$ 1.57
$ 1.51
(a)
Restructuring and other related items include asset impairment charges, recognition of future contractual obligations, employee severance costs, facility exit related charges, and other.
(b)
Other cost of goods sold includes charges for an intellectual property licensing claim, product claim related matters that were fully resolved in the fourth quarter of fiscal 2024, and acquisition integration related inventory costs.
(c)
Other costs in operating expenses and interest and other loss, net include gain or loss on investments and asset acquisition related costs.
(d)
Other income tax effects and adjustments relate to tax provision based on a non-GAAP income tax rate of 7.0% for the three months and year ended February 1, 2025, and three months ended November 2, 2024. Other income tax effects and adjustments relate to tax provision based on a non-GAAP income tax rate of 6.0% for the three months and year ended February 3, 2024. In the three months and year ended February 3, 2024, we excluded $289 million and $158 million, respectively, of non-recurring income tax expense.
(e)
Non-GAAP diluted weighted-average shares differs from GAAP diluted weighted-average shares due to the non-GAAP net income reported.
Marvell Technology, Inc.
Outlook for the First Quarter of Fiscal Year 2026
Reconciliations from GAAP to Non-GAAP (Unaudited)
(In millions, except per share amounts)
Outlook for Three Months Ended
May 3, 2025
GAAP net revenue
$1,875 +/- 5%
Special items:
—
Non-GAAP net revenue
$1,875 +/- 5%
GAAP gross margin
~ 50.5%
Special items:
Stock-based compensation
0.5 %
Amortization of acquired intangible assets
9.0 %
Non-GAAP gross margin
~ 60%
Total GAAP operating expenses
~ $712
Special items:
Stock-based compensation
144
Amortization of acquired intangible assets
76
Restructuring related charges and other
2
Total non-GAAP operating expenses
~ $490
GAAP diluted net income per share
$0.19 +/- $0.05
Special items:
Stock-based compensation
0.18
Amortization of acquired intangible assets
0.28
Other income tax effects and adjustments
(0.04)
Non-GAAP diluted net income per share
$0.61 +/- $0.05
Quarterly Revenue Trend (Unaudited)
Our product solutions serve five large end markets where our technology is essential: (i) data center, (ii) enterprise networking, (iii) carrier infrastructure, (iv) consumer, and (v) automotive/industrial. These markets and their corresponding customer products and applications are noted in the table below:
End market
Customer products and applications
Data center
• Cloud and on-premise Artificial intelligence (AI) systems
• Cloud and on-premise ethernet switching
• Cloud and on-premise network-attached storage (NAS)
• Cloud and on-premise AI servers
• Cloud and on-premise general-purpose servers
• Cloud and on-premise storage area networks
• Cloud and on-premise storage systems
• Data center interconnect (DCI)
Enterprise networking
• Campus and small medium enterprise routers
• Campus and small medium enterprise ethernet switches
• Campus and small medium enterprise wireless access points (WAPs)
• Network appliances (firewalls, and load balancers)
• Workstations
Carrier infrastructure
• Broadband access systems
• Ethernet switches
• Optical transport systems
• Routers
• Wireless radio access network (RAN) systems
Consumer
• Broadband gateways and routers
• Gaming consoles
• Home data storage
• Home wireless access points (WAPs)
• Personal Computers (PCs)
• Printers
• Set-top boxes
Automotive/industrial
• Advanced driver-assistance systems (ADAS)
• Autonomous vehicles (AV)
• In-vehicle networking
• Industrial ethernet switches
• United States military and government solutions
• Video surveillance
Quarterly Revenue Trend (Unaudited) (Continued)
Three Months Ended
% Change
Revenue by End Market
(In millions)
February 1,
2025
November 2,
2024
February 3,
2024
YoY
QoQ
Data center
$ 1,365.8
$ 1,101.1
$ 765.3
78 %
24 %
Enterprise networking
171.4
150.9
265.0
(35) %
14 %
Carrier infrastructure
105.8
84.7
170.0
(38) %
25 %
Consumer
88.7
96.5
143.9
(38) %
(8) %
Automotive/industrial
85.7
82.9
82.3
4 %
3 %
Total Net Revenue
$ 1,817.4
$ 1,516.1
$ 1,426.5
27 %
20 %
Three Months Ended
Revenue by End Market % of
Total
February 1,
2025
November 2,
2024
February 3,
2024
Data center
75 %
73 %
54 %
Enterprise networking
9 %
10 %
19 %
Carrier infrastructure
6 %
6 %
12 %
Consumer
5 %
6 %
10 %
Automotive/industrial
5 %
5 %
5 %
Total Net Revenue
100 %
100 %
100 %
For further information, contact:
Ashish Saran
Senior Vice President, Investor Relations
408-222-0777
ir@marvell.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/marvell-technology-inc-reports-fourth-quarter-and-fiscal-year-2025-financial-results-302393619.html
SOURCE Marvell
You may like
Technology
HelloNation Article Highlights Sterile Compounding and Medication Safety With Insights From Compounding Pharmacist Expert Laura Temple
Published
46 minutes agoon
July 21, 2026By
The article explains how sterile compounded medications are prepared to reduce the risk of contamination and support safe, customized treatments.
AZLE, Texas, July 21, 2026 /PRNewswire/ — What does sterile compounding mean for medication safety? HelloNation has published an article explaining how sterile compounding helps pharmacies prepare highly specialized medications while adhering to strict contamination-prevention procedures.
The article features insights from Laura Temple, Compounding Pharmacist Expert and Owner of Laura’s Pharmacy in Azle, Texas. It explains that sterile compounding is a specialized process for preparing medications in carefully controlled environments designed to reduce the risk of contamination. Sterile compounded medications are often used for injections, eye drops, IV medications, and other therapies that require the highest levels of cleanliness and precision.
The HelloNation article explains that sterile compounded medications differ from commercially manufactured drugs because they are prepared individually for a patient’s unique medical needs. Physicians may prescribe compounded prescriptions when a patient requires a customized dosage, a combination medication, or a treatment not commercially available. Because these medications often bypass the body’s natural defenses, medication safety depends on strict preparation standards throughout the compounding process.
The article describes how pharmacies that provide sterile compounding rely on cleanroom environments equipped with filtered-air systems, specialized equipment, and contamination-prevention protocols. Pharmacists and technicians follow detailed gowning, sterilization, and handwashing procedures before handling medication ingredients. These measures are designed to support medication safety by limiting exposure to bacteria, particles, and other contaminants.
According to the article, environmental monitoring also plays a critical role in sterile compounding. Temperature control, air quality testing, and routine equipment inspections help maintain consistent preparation standards. The article notes that sterile compounded medications may undergo additional quality assurance checks before being dispensed to patients. These procedures help support both treatment effectiveness and patient safety.
The HelloNation article also explains that pharmacies performing sterile compounding are expected to follow USP guidelines established for sterile preparation. These USP guidelines outline requirements for cleanroom pharmacy operations, environmental testing, employee training, and quality assurance practices. The article emphasizes that maintaining compliance with USP guidelines helps reinforce contamination prevention and consistent preparation standards for compounded prescriptions.
Patients seeking sterile compounded medications may also look for pharmacies that participate in accreditation programs or are overseen by state boards. The article explains that these programs review safety procedures, documentation practices, and facility standards to help maintain medication safety. Regular environmental monitoring and staff competency evaluations are also identified as important safeguards in sterile compounding operations.
The article further explains that communication between pharmacists, healthcare providers, and patients remains an important part of safe compounded prescriptions. Compounding pharmacists review prescriptions carefully, confirm dosing instructions, and evaluate ingredient compatibility before preparation begins. This collaborative approach supports medication safety by reducing the risk of errors and ensuring treatments meet individual patient needs.
The article concludes that sterile compounding continues to play an important role in healthcare, particularly for patients requiring customized therapies that are unavailable through traditional manufacturing channels. Whether preparing IV medications, injectable therapies, or other sterile compounded medications, pharmacies rely on contamination prevention procedures and strict preparation standards to support patient care. The article notes that understanding how sterile compounding works can help patients feel more informed about the safety measures involved in preparing specialized medications.
What Sterile Compounding Means for Medication Safety features insights from Laura Temple, a compounding pharmacist expert at Laura’s Pharmacy in Azle, Texas, on HelloNation.
About HelloNation
HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.
View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-article-highlights-sterile-compounding-and-medication-safety-with-insights-from-compounding-pharmacist-expert-laura-temple-302831275.html
SOURCE HelloNation
Technology
CIOs Forced to Rethink Manual Compliance Processes as Regulatory Complexity Rises, Says Info-Tech Research Group
Published
46 minutes agoon
July 21, 2026By
Regulatory demands are increasing in volume, complexity, and speed, leaving many organizations reliant on fragmented, manual approaches that slow response times and increase risk. New insights from Info-Tech Research Group show that organizations need to adopt more structured and scalable approaches to keep pace with regulatory change. The firm’s recently published blueprint, Build a Regulatory IT Response Engine, provides frameworks, tools, and step-by-step guidance to help organizations translate regulatory requirements into actionable IT controls and prioritized initiatives.
ARLINGTON, Va., July 21, 2026 /PRNewswire/ — Growing regulatory pressure across jurisdictions is forcing organizations to rethink how they interpret, prioritize, and execute compliance requirements. Many IT teams continue to operate with inconsistent processes and limited coordination, resulting in delayed initiatives and increased exposure to financial and reputational risk. Info-Tech’s blueprint, Build a Regulatory IT Response Engine, introduces a coordinated and repeatable approach to help IT leaders operationalize compliance and improve execution outcomes.
Info-Tech’s findings indicate that while organizations recognize the need for faster and more consistent regulatory response, they continue to face barriers such as fragmented interpretation of requirements, weak prioritization, and limited scalability. AI-enabled tools can help streamline analysis and accelerate response planning, but without a coordinated approach grounded in governance and human oversight, those benefits are difficult to realize.
“Regulatory response is becoming too complex to manage through disconnected, manual processes,” says Ahmad Jowhar, senior research analyst at Info-Tech Research Group. “IT leaders need a repeatable way to interpret requirements, prioritize action, and use AI to accelerate planning without losing the governance and oversight needed to execute effectively.”
Key Challenges IT Leaders Face in Regulatory Response
Despite ongoing investments in compliance, organizations continue to face systemic challenges that hinder effective execution. Info-Tech’s blueprint highlights several areas where IT and compliance leaders struggle most:
Fragmented and manual processes that slow regulatory interpretation and response.Inconsistent application of regulatory requirements across teams and jurisdictions.Poor prioritization of IT initiatives, leading to missed deadlines and duplicated effort.Limited scalability to manage increasing regulatory volume and complexity.Misalignment between compliance activities and broader business priorities.
Info-Tech’s Framework for Building a Regulatory IT Response Engine
To address these challenges, Info-Tech recommends a structured, AI-enabled approach that improves consistency, speed, and scalability. The firm’s Build a Regulatory IT Response Engine blueprint outlines the following key priorities for IT leaders:
Define the regulatory landscape: Establish organizational context, governance structures, and a centralized inventory of applicable regulations.Translate requirements into IT controls: Use AI-enabled analysis and structured assessments to convert regulatory obligations into actionable controls.Prioritize IT initiatives: Align initiatives based on cost, effort, impact, and regulatory timelines to reduce execution risk.Build and communicate a roadmap: Develop a clear, resource-aligned roadmap to guide execution and stakeholder alignment.Establish a repeatable process: Continuously monitor, adapt, and refine regulatory response capabilities to maintain compliance over time.
Organizations that adopt this structured approach can move from reactive compliance efforts to a more proactive and scalable model that shortens response timelines, reduces manual effort, and strengthens execution.
The firm’s Build a Regulatory IT Response Engine blueprint includes practical tools such as a Regulation Inventory Tool, a Regulatory Response IT Action Plan Tool, a Communication Deck Template, and a Compliance Program Framework. By applying these resources, IT leaders can standardize regulatory responses, improve prioritization, and help ensure compliance initiatives are executed on time and in alignment with business priorities.
For exclusive and timely commentary from Info-Tech’s experts, including Ahmad Jowhar, and access to the complete Build a Regulatory IT Response Engine blueprint, please contact pr@infotech.com.
About Info-Tech Research Group
Info-Tech Research Group is the “get things done” partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform their organizations through AI, strategic foresight, step-by-step methodologies, practical tools, industry-leading advisory, and training programs. For nearly 30 years, tens of thousands of private and public organizations have trusted Info-Tech to lead their most important initiatives through periods of change and deliver outcomes that truly matter.
To learn more about Info-Tech’s HR research and advisory services, visit McLean & Company, and for data-driven software buying insights and vendor evaluations, visit the firm’s SoftwareReviews platform.
Media professionals can register for unrestricted access to research across IT, HR, and software and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com.
For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cios-forced-to-rethink-manual-compliance-processes-as-regulatory-complexity-rises-says-info-tech-research-group-302831286.html
SOURCE Info-Tech Research Group
Technology
Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026
Published
46 minutes agoon
July 21, 2026By
LOS GATOS, Calif., July 21, 2026 /PRNewswire/ — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, announced today that it plans to release its second quarter 2026 financial results after the market closes on Tuesday, Aug. 4, 2026.
The company will host a live video Zoom webinar at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, Aug. 4, 2026, to discuss the results. The live webinar can be accessed through Atomera’s investor relations website at https://ir.atomera.com. A replay of the webcast will be available for 12 months. To pre-register for the webinar, use the following link.
https://atomera.zoom.us/webinar/register/WN_OJFbTWe1SIyV69LLdDadCw
About Atomera
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-to-announce-second-quarter-2026-financial-results-and-host-webinar-on-tuesday-august-4-2026-302830602.html
SOURCE Atomera Incorporated
HelloNation Article Highlights Sterile Compounding and Medication Safety With Insights From Compounding Pharmacist Expert Laura Temple
CIOs Forced to Rethink Manual Compliance Processes as Regulatory Complexity Rises, Says Info-Tech Research Group
Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market5 days agoBitcoin outlook improves amid 6% weekly gain: Can BTC bulls push higher?
-
Technology5 days agoTimed with the Canton Fair, Connexion ShenZhen 2026 Unveils Major Fourth-Edition Upgrades as a Greater Bay Area Mega Sourcing Event
-
Coin Market4 days agoThe British Virgin Islands are a top crypto hub no one ever talks about: Here’s why
-
Technology4 days agoGlobal Times: China sends fresh signal on global AI cooperation at WAIC
-
Coin Market5 days agoTrump teleprompter operator made $100K betting on Kalshi markets tied to speeches: ABC
-
Technology5 days agoGrand Bargain Project Announces Procedural Change that Will Turn Congress into a Problem-Solving Institution Within Days
-
Technology5 days agoDrake Expands End-to-End Professional Services with Launch of Drake Audit Defense™
-
Technology5 days agoTexas Instruments board declares third quarter 2026 quarterly dividend
